# FDA Inspection 1194604 - Regenerative Biologics Inc - January 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/b7e50064-957c-4a4e-ae47-855b4afb3a7c
Source feed: FDA_Inspections

> FDA Inspection 1194604 for Regenerative Biologics Inc on January 11, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194604
- Company Name: Regenerative Biologics Inc
- Inspection Date: 2023-01-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1194604 - 2023-01-11](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/e73b9cbe-56b9-4a0b-b460-7a05f7eab4a3)
- [FDA Inspection 1194604 - 2023-01-11](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/2a2e2306-81d3-4dff-8325-f72597ee5da4)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/164eb1d8-0996-45f8-bb98-9d8712860cd0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d